Wordt geladen...
Nurse-administered intravitreal injections of anti-VEGF: study protocol for noninferiority randomized controlled trial of safety, cost and patient satisfaction
BACKGROUND: Intravitreal injections (IVI) of anti-vascular endothelial growth factor (anti-VEGF) now improve or stabilize visual acuity in a number of previously untreatable eye diseases, of which the main are age-related macular degeneration, retinal vein occlusion and diabetic macular edema. Most...
Bewaard in:
| Gepubliceerd in: | BMC Ophthalmol |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5045663/ https://ncbi.nlm.nih.gov/pubmed/27716253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-016-0348-4 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|